What Manulife's Withdrawn Leveraged Insurance Product Reveals About Tax-Driven Wealth Plans

In 2026, Manulife suspended sales of certain high-leverage insurance products in Hong Kong after regulators started asking pointed questions about how those policies were being financed. These products came from one of the largest insurers in the world, they were sold through proper channels, and they had looked sound in every illustration. Then the shelf was empty.

That episode is a useful warning for anyone in Atlantic Canada being shown a leveraged insurance plan as a tax solution. A plan that depends on one specific product is depending on regulators staying comfortable with it. When a corporation's passive investment income in PEI can be taxed at roughly half, a tax-exempt policy funded with borrowed money looks very attractive. It can work well. But the decision you're making covers ten or twenty years, and the product carrying it may not be available for that long.

A leveraged policy is three arrangements, and each lasts a different length of time

Take a typical Immediate Financing Arrangement. A business owner in Charlottetown buys a permanent policy through the corporation, pledges it to a bank, and borrows back most of the premium each year to reinvest. On paper it's one strategy. In practice it rests on three separate commitments.

The first is the insurance contract. Guaranteed values in a whole life policy are a legal obligation, and the insurer has to honour them even if it stops selling that policy to new clients the next day.

The second is the tax treatment. Under section 148 of the Income Tax Act, a policy that passes the exemption test grows without annual tax. That status exists because Parliament allows it, and Parliament has narrowed it before. The 2017 changes reduced how much growth newer policies can shelter compared with older ones.

The third is the loan, and it's the weakest. A bank's willingness to lend against your policy, at what rate and on what collateral terms, is usually reviewed every year. When prime moved sharply between 2022 and 2026, borrowers in these arrangements found out quickly how much the interest line could change the whole picture. OSFI can also change how banks treat this lending through guidance, which moves much faster than legislation.

Grandfathering protects what you already hold

The usual reassurance is fair as far as it goes. Canadian regulators and the CRA have historically avoided taxing existing policies retroactively, so new rules generally apply to new contracts. If one big bank pulls back from insurance lending, other lenders usually step in at a higher price.

Look at what that protects, though. The policy you signed is safe. The plan most clients are sold involves more than that: they expect to add premiums for years, buy more coverage as the company grows, and keep borrowing on similar terms. Grandfathering does nothing for the second policy you haven't bought yet, the funding you expected to scale up in year six, or the loan renewal your projection assumed. A product pulled in Hong Kong in 2026 can also hint at where Canadian regulators might look next, since regulators watch each other.

Test the outcome separately from the product

What you want is a result: less tax on corporate surplus, liquidity you can use, money moved efficiently to the next generation. The product is just today's way of getting there. Before committing, write down the result in plain terms, then ask your advisor how you would get there if this product disappeared tomorrow. Would a different policy work? A different lender? A non-insurance approach, like tax-deductible investment borrowing through a Smith Manoeuvre™ on personal real estate, or a different timing for dividends and salary?

If there's a reasonable second route, the insurance structure is a good tool you've chosen. If there isn't, and the whole projection falls apart without this one contract and this one bank, then the plan depends entirely on regulators continuing to tolerate the product.